✦ LIBER ✦

42-4 - Preclinical profile of befloxatone, a reversible and selective MAO-A inhibitor

✍ Scribed by O. Curet; D. Caille; B. Scatton

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical profile of befloxatone, a ne

✍ O. Curet; G. Damoiseau-Ovens; C. Sauvage; N. Sontag; P. Avenet; H. Depoortere; D 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 570 KB

S-51-4 - Pharmacological profile of befl

✍ O. Curet; D. Caille; J. Benavides; H. Depoortere; B. Scatton 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Autoradiographic distribution of [3H]-be

✍ Sauvage, C.; Curet, O.; Damoiseau, G.; Benavides, J.; Scatton, B. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 238 KB

24-5 - Enhancement of 5-HT transmission

✍ P. Blier; N. Haddjeri; C. de Montigny 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Phase I study of single ascending doses

✍ Ansseau, M.; Caillé, P.; Derks, C.; Cieren-Puiseux, I.; Wauthy, J.; Ego, D.; Cur 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Substituted Xanthones as Selective and R

✍ Ulrike Thull; Silvia Kneubühler; Bernard Testa; M. Fernanda M. Borges; Madalena 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 596 KB